Ich stimme der Verwendung von Cookies zu. Auch wenn ich diese Website weiter nutze, gilt dies als Zustimmung.

Bitte lesen und akzeptieren Sie die Datenschutzinformation und Cookie-Informationen, damit Sie unser Angebot weiter nutzen können. Natürlich können Sie diese Einwilligung jederzeit widerrufen.






21st Austria weekly - Valneva, Verbund (16/01/2019)

20.01.2019

Valneva: Austrian French Biotech company Valneva announced the signing of a new USD 59 mn contract with the U.S. government Department of Defense for the supply of its Japanese encephalitis (JE) vaccine IXIARO®. Under the terms of the agreement, Valneva will supply IXIARO® doses to the Defense Logistics Agency of the U.S. Department of Defense, through 2019 and the beginning of 2020 with a value of USD 59 mn guaranteed and potentially worth up to USD 70 mn. A delivery schedule is being prepared and supply shipments will commence immediately.
Valneva: weekly performance: 6.51%

Verbund: Austrian utility company Verbund announced an increase in earnings forecast for financial year 2018. As a result of positive non-recurring effects from impairment testing, the company now expects a Group result of approximately Euro 430 mn for financial year 2018 (former forecast: approximately Euro 340 million). The forecast for EBITDA and the Group result adjusted for non-recurring effects, which serves as the basis for calculating the dividend, remains unchanged at approximately Euro 870 mn and approximately Euro 335 mn respectively. A favourable change in parameters in the energy market, primarily an increase in electricity price forecasts, caused these positive non-recurring effects from impairment testing. The resulting value increases concern hydropower in Austria and Germany and wind energy in Romania.
Verbund: weekly performance: 5.22%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (16/01/2019)


Partners









latest 21st Austria

21st Austria weekly - Valneva, Verbund (16/01/2019)


20.01.2019, 1533 Zeichen



Valneva: Austrian French Biotech company Valneva announced the signing of a new USD 59 mn contract with the U.S. government Department of Defense for the supply of its Japanese encephalitis (JE) vaccine IXIARO®. Under the terms of the agreement, Valneva will supply IXIARO® doses to the Defense Logistics Agency of the U.S. Department of Defense, through 2019 and the beginning of 2020 with a value of USD 59 mn guaranteed and potentially worth up to USD 70 mn. A delivery schedule is being prepared and supply shipments will commence immediately.
Valneva: weekly performance: 6.51%

Verbund: Austrian utility company Verbund announced an increase in earnings forecast for financial year 2018. As a result of positive non-recurring effects from impairment testing, the company now expects a Group result of approximately Euro 430 mn for financial year 2018 (former forecast: approximately Euro 340 million). The forecast for EBITDA and the Group result adjusted for non-recurring effects, which serves as the basis for calculating the dividend, remains unchanged at approximately Euro 870 mn and approximately Euro 335 mn respectively. A favourable change in parameters in the energy market, primarily an increase in electricity price forecasts, caused these positive non-recurring effects from impairment testing. The resulting value increases concern hydropower in Austria and Germany and wind energy in Romania.
Verbund: weekly performance: 5.22%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (16/01/2019)



BSN Podcasts
Christian Drastil: Wiener Börse Plausch

Börsenradio Live-Blick, Do. 30.5.24: DAX an Fronleichnam zunächst leichter, SAP mit Volumen, Siemens Energy mal schwächer




 

Bildnachweis

Aktien auf dem Radar:S Immo, SBO, Rosenbauer, Flughafen Wien, Mayr-Melnhof, RBI, Marinomed Biotech, Österreichische Post, VIG, Wienerberger, DO&CO, Strabag, OMV, Austriacard Holdings AG, EuroTeleSites AG, Kostad, Zumtobel, Frequentis, Agrana, Amag, CA Immo, Erste Group, EVN, Immofinanz, Semperit, Telekom Austria, Uniqa.


Random Partner

BNP Paribas
BNP Paribas ist eine führende europäische Bank mit internationaler Reichweite. Sie ist mit mehr als 190.000 Mitarbeitern in 74 Ländern vertreten, davon über 146.000 in Europa. BNP Paribas ist in vielen Bereichen Marktführer oder besetzt Schlüsselpositionen am Markt und gehört weltweit zu den kapitalstärksten Banken.

>> Besuchen Sie 68 weitere Partner auf boerse-social.com/partner


Useletter

Die Useletter "Morning Xpresso" und "Evening Xtrakt" heben sich deutlich von den gängigen Newslettern ab. Beispiele ansehen bzw. kostenfrei anmelden. Wichtige Börse-Infos garantiert.

Newsletter abonnieren

Runplugged

Infos über neue Financial Literacy Audio Files für die Runplugged App
(kostenfrei downloaden über http://runplugged.com/spreadit)

per Newsletter erhalten